联系客服

600436 沪市 片仔癀


首页 公告 600436:漳州片仔癀药业股份有限公司2022年第一季度主要经营数据公告

600436:漳州片仔癀药业股份有限公司2022年第一季度主要经营数据公告

公告日期:2022-04-23

600436:漳州片仔癀药业股份有限公司2022年第一季度主要经营数据公告 PDF查看PDF原文

 证券代码:600436    证券简称:片仔癀    公告编号:2022-024
          漳州片仔癀药业股份有限公司

        2022 年第一季度主要经营数据公告

    本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏,并对其内容的真实性、准确性和完整性承担个别及连带责任。

  根据《上海证券交易所上市公司自律监管指引第 3 号——行业信息披露》(2022 年修订)《上市公司行业信息披露指引第六号——医药制造》(2022 年修订)等相关法律法规,漳州片仔癀药业股份有限公司(以下简称“公司”)现将 2022 年第一季度主要经营数据披露如下:

  一、 公司 2022 年第一季度主营业务分行业情况

                                            单位:万元人民币

                                          主营业  主营业

                                  毛利

          主营业务    主营业务          务收入  务成本    毛利率

  行业                              率

            收入        成本            增长率  增长率  增减情况
                                  (%)

                                          (%)  (%)

  医药                                                    减少 0.76 个
          117,871.21  26,247.46  77.73  21.19  25.48

 制造业                                                      百分点

  医药                                                    增加 3.06 个
          94,092.34  84,145.81  10.57  17.67  13.77

 流通业                                                      百分点

 医药行                                                  增加 1.46 个
          211,963.55  110,393.27  47.92  19.60  16.35

 业小计                                                      百分点

化妆品、                                                  增加 6.71 个
          19,040.03    5,884.52  69.09  -13.20  -28.69

 日化业                                                      百分点

                                                          减少 12.18
 食品业    3,197.61    2,906.43  9.11  561.24  663.55

                                                          个百分点

                                                          增加 0.96 个
  合计    234,201.19  119,184.22  49.11  17.31  15.14

                                                            百分点


  二、 公司 2022 年第一季度主营业务分类别情况

                                            单位:万元人民币

                                  毛利  主营业  主营业

          主营业务    主营业务          务收入  务成本    毛利率

 分类别                            率

            收入        成本            增长率  增长率  增减情况
                                  (%)

                                          (%)  (%)

  肝病                                                    减少 0.82 个
          110,113.48  21,772.27  80.23  19.70  24.91

  用药                                                      百分点

 心脑血                                                  增加 3.95 个
            6,584.98    3,459.12  47.47  142.36  125.40

 管用药                                                      百分点

                                                          减少 32.35
  其他      1,172.75    1,016.07  13.36  38.21  120.58

                                                            个百分点

  医药

                                                          减少 0.76 个
 制造业  117,871.21    26,247.46  77.73  21.19  25.48

                                                            百分点

  小计

  医药                                                    增加 3.06 个
          94,092.34    84,145.81  10.57  17.67  13.77

 流通业                                                      百分点

 医药行                                                  增加 1.46 个
          211,963.55  110,393.27  47.92  19.60  16.35

 业小计                                                      百分点

化妆品、                                                  增加 6.71 个
          19,040.03    5,884.52  69.09  -13.20  -28.69

 日化业                                                      百分点

                                                          减少 12.18
 食品业    3,197.61    2,906.43  9.11  561.24  663.55

                                                            个百分点

                                                          增加 0.96 个
  合计    234,201.19  119,184.22  49.11  17.31  15.14

                                                            百分点


  三、 公司 2022 年第一季度主营业务分地区情况

                                            单位:万元人民币

        地区              主营业务收入        同比上年增减(%)

      东北地区                    2,961.06                  -36.43

      华北地区                    15,339.99                  40.51

      华东地区                  159,536.70                  19.59

      华南地区                    24,202.72                  16.01

      华中地区                    9,706.65                    8.67

      西北地区                    2,145.32                  17.80

      西南地区                    6,807.87                    2.02

      境外地区                    13,500.88                    9.11

        合计                    234,201.19                  17.31

  说明:(1)上表中地区分布以客户公司所在地划分。

        (2)境内各地区收入变化主要系医药行业销售变化所致。
  四、其它对公司生产经营产生重大影响的事件

  无。

  上述的主要经营数据信息来源于公司报告期内财务数据,且未经审计,仅供投资者及时了解公司生产经营情况之用。敬请广大投资者审慎使用,理性投资,注意风险。

  特此公告。

                                  漳州片仔癀药业股份有限公司
                                        董  事  会

                                        2022 年 4 月 23 日

[点击查看PDF原文]